January 30-31, 2018
San Diego, CA

Latest News

news-47

Performance of a New HPV and Biomarker Assay in Management of hrHPV Positive Women

“Subanalysis of the Ongoing Multicenter TRACE Clinical Trial (n>6,000) to Evaluate POU4F3 as a Potential Biomarker of Cervical Precancer and Cancer…”

Read in full

 

news-46

The state of the art in prediction of breast cancer relapse using cell-free circulating tumor DNA liquid biopsies

“Other biomarkers are under development, among which the analysis of cell-free circulating tumor DNA (ctDNA) is one of the most exciting…”

Read in full

 

news-45

Liquid biopsy in the practice of neo-oncology

“Selecting the optimal platform for molecular diagnostic profiling is a crucial step in the management of patients with advanced lung…”

Read in full

news-44

Circulating Phospholipids as Biomarkers of Breast Cancer: A Review

“A growing field of interest is the association between breast cancer (tissue and cells) and lipids, which is documented in the literature, and may be considered as a leading candidate in the breast cancer detection…”

Read in full

 

news-43

 Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies

“CSF tumor-derived cfDNA has the potential to serve as a diagnostic tool that complements MRI and may be more sensitive than conventional cytology…”

Read in full

 

 news-36

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA

“By analyzing DNA in tumor samples and blood of lymphoma patients, Scherer et al. have shown that specific genetic characteristics can determine each tumor’s cell of origin and identify tumors…”

Read in full

 news-35

The potential of liquid biopsies

“In this review, we highlight the opportunities and clinical as well as research applications of liquid biopsy in NSCLC patients…”

Read in full

 news-34

Targeted treatment of brainstem neurohistiocytosis guided by urinary cell-free DNA

“Objective: To identify a treatment-responsive BRAFV600E mutation in brainstem neurohistiocytosis, where no lesional tissue was readily obtainable, using a cell-free DNA approach..”

Read in full

 news-33

A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative

Read in full

 news-32

 Liquid biopsy in lung cancer: present and future

“Liquid biopsies are already offering all sorts of additional data that could not be obtained in any other way…”

Read in full

View more